FAO

Other Metabolism Related Inhibitors

Dehydrogenase Transferase DPP Aminopeptidase Procollagen C Proteinase P450 (e.g. CYP17) Phospholipase (e.g. PLA) Factor Xa PDE DHFR

Cat.No.	Product Name	Information	Product Use Citations	Product Validations
S4543	Trimetazidine dihydrochloride	Trimetazidine dihydrochloride (Yoshimilon, Kyurinett, Vastarel F) is a kind of drug for treatment of chronic ischemic disorders. It improves myocardial glucose utilization through inhibition of fatty acid metabolism, known as fatty acid oxidation inhibitor.	Cancer Research, May 15, 2023, 1711-1724 Frontiers in Pharmacology, July 13, 2022, 918335 mBio, April 25, 2023, e0291922

Cat.No.

Product Name

Information

Product Use Citations

Product Validations

S4543

Trimetazidine dihydrochloride

Trimetazidine dihydrochloride (Yoshimilon, Kyurinett, Vastarel F) is a kind of drug for treatment of chronic ischemic disorders. It improves myocardial glucose utilization through inhibition of fatty acid metabolism, known as fatty acid oxidation inhibitor.

Cancer Research, May 15, 2023, 1711-1724

Frontiers in Pharmacology, July 13, 2022, 918335

mBio, April 25, 2023, e0291922